Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · IEX Real-Time Price · USD
2.530
+0.060 (2.43%)
At close: Jul 12, 2024, 4:00 PM
2.500
-0.030 (-1.19%)
After-hours: Jul 12, 2024, 7:53 PM EDT

Cellectar Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2004
Selling, General & Admin
10.759.596.545.155.18
Upgrade
Research & Development
28.2119.2217.5910.149
Upgrade
Operating Expenses
38.9628.8124.1315.2914.18
Upgrade
Operating Income
-38.96-28.81-24.13-15.29-14.18
Upgrade
Other Expense / Income
-0.92-0.15-0.01-0.2-0.09
Upgrade
Pretax Income
-38.04-28.66-24.12-15.09-14.09
Upgrade
Income Tax
-0.06-0.06000
Upgrade
Net Income
-37.98-28.6-24.12-15.09-14.09
Upgrade
Shares Outstanding (Basic)
127621
Upgrade
Shares Outstanding (Diluted)
127621
Upgrade
Shares Change
73.22%27.09%180.20%158.14%159.12%
Upgrade
EPS (Basic)
-3.11-4.05-4.35-7.60-18.40
Upgrade
EPS (Diluted)
-3.11-4.05-4.35-7.60-18.40
Upgrade
Free Cash Flow
-33.24-25.45-22.71-14-11.72
Upgrade
Free Cash Flow Per Share
-2.72-3.61-4.09-7.06-15.27
Upgrade
EBITDA
-37.79-28.42-23.89-14.89-13.9
Upgrade
Depreciation & Amortization
0.250.240.230.210.19
Upgrade
EBIT
-38.04-28.66-24.12-15.09-14.09
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).